Literature DB >> 6768762

Effects of calcitonin on basal and thyrotropin-releasing hormone-stimulated prolactin secretion in man.

R Isaac, R Merceron, G Caillens, J P Raymond, R Ardaillou.   

Abstract

Plasma PRL fell in nine healthy subjects and four patients with hyperprolactinemia after iv administration of salmon calcitonin (CT). The maximum fall was observed 30--60 min after the infusion. There was no change in the plasma concentrations of the other anterior pituitary hormones tested (GH, FSH, LH, and TSH). In five healthy subjects, TRH was injected 60 min after the CT infusion. This protocol was repeated in the same subjects at 3-day intervals, except CT was not administered. Plasma PRL before TRH injection was clearly lower when CT had been administered. Plasma concentrations of the other anterior pituitary hormones did not change. PRL and TSH responses to TRH were markedly inhibited when CT had been previously infused. These observations are in agreement with preceeding studies showing a similar effect of CT on the plasma concentration of various other polypeptide hormones. This general effect of CT could be attributed to a change in intracellular calcium of the secreting cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768762     DOI: 10.1210/jcem-50-6-1011

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

2.  Does calcitonin modulate anterior pituitary hormone secretion?

Authors:  G P Ceda; G Valenti; E Dall'Aglio; E Palummeri; D Provvedini; U Butturini
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

3.  Inhibitory effects of centrally administered /ASU1-7/eel calcitonin on basal and stimulated prolactin release in rats.

Authors:  V Sibilia; C Netti; F Guidobono; I Villa; A Pecile
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

4.  Calcitonin inhibits prolactin gene transcription in rat pituitary cells.

Authors:  Q Xue-Zhang; S M Stanley; G V Shah
Journal:  Endocrine       Date:  1995-06       Impact factor: 3.633

5.  Calcitonin suppresses growth hormone (GH) response to growth hormone-releasing hormone (GHRH) in man.

Authors:  A M Lengyel; A L Toledo; M A Czepielewski; J G Vieira; A R Chacra
Journal:  J Endocrinol Invest       Date:  1989-01       Impact factor: 4.256

6.  Effect of 1,25-dihydroxyvitamin D3 and nifedipine on prolactin release in normal man.

Authors:  D Verbeelen; L Vanhaelst; M Fuss; A C Van Steirteghem
Journal:  J Endocrinol Invest       Date:  1985-04       Impact factor: 4.256

7.  Increased forearm bone mineral content after bromocriptine treatment in hyperprolactinemia.

Authors:  M P Caraceni; E Corghi; S Ortolani; S Casazza; A D'Alberton; T Motta
Journal:  Calcif Tissue Int       Date:  1985-12       Impact factor: 4.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.